Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the target of a large growth in short interest in the month of October. As of October 30th, there was short interest totaling 33,454 shares, a growth of 1,608.6% from the October 15th total of 1,958 shares. Currently, 2.7% of the shares of the company are short sold. Based on an average trading volume of 18,461 shares, the days-to-cover ratio is currently 1.8 days.
Global X HealthTech ETF Trading Down 2.1%
HEAL stock traded down $0.66 on Tuesday, hitting $30.70. The company’s stock had a trading volume of 5,564 shares, compared to its average volume of 10,857. The firm has a 50 day moving average of $29.84 and a two-hundred day moving average of $27.32. Global X HealthTech ETF has a 1 year low of $23.00 and a 1 year high of $32.15. The stock has a market cap of $38.06 million, a price-to-earnings ratio of 28.10 and a beta of 1.12.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. Royal Bank of Canada lifted its position in Global X HealthTech ETF by 39.4% during the 1st quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock worth $62,000 after acquiring an additional 736 shares during the period. Farther Finance Advisors LLC lifted its holdings in shares of Global X HealthTech ETF by 4.3% during the third quarter. Farther Finance Advisors LLC now owns 23,037 shares of the company’s stock worth $680,000 after purchasing an additional 950 shares during the period. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors grew its position in Global X HealthTech ETF by 28.3% in the 3rd quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 195,122 shares of the company’s stock valued at $5,758,000 after buying an additional 43,075 shares during the last quarter.
About Global X HealthTech ETF
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
Featured Stories
- Five stocks we like better than Global X HealthTech ETF
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
